Company Analysis

MoonLake Immunotherapeutics (MLTX)

Nasdaq: MLTX · Pharmaceutical Preparations · Zug, CH · filing with the SEC since 2020
Grade5.5
◀ Past 4.6● Present 5.9▶ Future 5.8
7 est.

Filings

221 filings since 2017 beside 110 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 21, 2026.

Filings a yearinsider forms included
25266664444957
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Jun 9, 2026.SEC letters: 3 in the last 36 months, the newest May 13, 2024.
Insider forms 110

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2026 8-K item 8.01 Other event · Current report
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 S-8 Employee stock plan registration
Aug 10, 2026 S-3ASR Shelf registration
Aug 10, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 15, 2026 8-K item 8.01 Other event · Current report Jul 14, 2026
Jun 29, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 25, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jun 23, 2026
Jun 24, 2026 424B5 Shelf offering
Jun 22, 2026 424B5 Shelf offering
Jun 22, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Jun 21, 2026
Jun 9, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 4, 2026
Jun 1, 2026 8-K item 1.01 Major agreement signed · Current report May 22, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report May 10, 2026
Apr 21, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 21, 2026 DEFA14A Extra proxy material
Apr 21, 2026 DEF 14A Proxy statement Jun 4, 2026
Apr 2, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 25, 2026 10-K Annual report Dec 31, 2025
Feb 23, 2026 8-K items 1.01, 2.02, 2.03, 5.02, 7.01, 8.01, 9.01 Major agreement signed; Results released; New debt or obligation taken on; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report Feb 18, 2026
Feb 17, 2026 SCHEDULE 13G Large holder notice
Jan 8, 2026 8-K items 8.01, 9.01 Other event · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 12, 2025 SCHEDULE 13G Large holder notice
Nov 10, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 5, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report
Nov 5, 2025 424B5 Shelf offering
Nov 5, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 1, 2025 SCHEDULE 13G/A Large holder update, amended
Sep 29, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 14, 2025 SCHEDULE 13G Large holder notice
40 of 221 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MLTX · research, not advice